Xylyx Bio is a New York-based biotechnology company that specializes in harnessing systemic physiology for transformative discovery and regeneration in the field of regenerative medicine. Their innovative approach involves engineering systemic physiology to enable whole organ regeneration, tissue repair, and predictive drug testing using proprietary technologies such as the Inspirex organ support platform, Matrikynes bioactive peptides, and In Matrico models and assays.
With a focus on increasing the utilization of donor organs for life-saving transplantation, Xylyx Bio's Inspirex platform rehabilitates donor organs by cross-circulation with a xenosupport pig, extending the time and opportunity for organ evaluation, therapeutic intervention, and cellular regeneration. Their Matrikynes peptides promote functional tissue repair by activating intracellular signaling pathways, while their In Matrico models and assays provide physiologically relevant, predictive cell-based systems for 3D drug testing. Through their powerful platform technologies, Xylyx Bio aims to advance regenerative medicine and save lives.
Generated from the website